Kane Logo Cropped TransBG.png
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.
25 juin 2024 08h30 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, June 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has entered into a worldwide license agreement with...
Kane Logo Cropped TransBG.png
Kane Biotech Expands its Wound Care Portfolio with Patented Schultz Biofilm Wound Map
15 mai 2024 08h00 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, May 15, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces its intent to commercialize the patented assay...
Kane Logo Cropped TransBG.png
Kane Biotech to Host Investor Webinar
16 avr. 2024 09h15 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, April 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane”) announces that it will be hosting a webinar on Thursday April 18th, 2024 at 4:15pm Eastern...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Improved Third Quarter 2023 Financial Results
28 nov. 2023 16h05 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its third quarter 2023 financial results. Third...
Kane Logo Cropped TransBG.png
Kane Biotech to Release Third Quarter 2023 Financial Results on November 28, 2023 – Conference Call to Follow
21 nov. 2023 07h45 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Logo Cropped TransBG.png
Kane Biotech to Release First Quarter 2023 Financial Results on May 25, 2023 – Conference Call to Follow
18 mai 2023 16h05 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, May 18, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Featured Image for Broad Institute of MIT and Harvard
Launch of the Merkin Prize in Biomedical Technology
31 oct. 2022 13h00 HE | Broad Institute of MIT and Harvard
CAMBRIDGE, Mass., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Nominations are now open for the first award of the Richard N. Merkin Prize in Biomedical Technology, which recognizes novel technologies that...
researchdrivelogo.jpg
Global Augmented Reality Market Predicted to Garner a Revenue of $65,323.4 Million in the 2020 to 2028 Timeframe, Growing at a Healthy CAGR of 30.9% [218-Pages] | Research Dive
28 sept. 2022 09h05 HE | Research Dive
New York, USA, Sept. 28, 2022 (GLOBE NEWSWIRE) -- According to Research Dive’s newly published report, the global augmented reality market is predicted to grow at a stable CAGR of 30.9%, thereby...
Akadeum Life Sciences Announces New Early Access Launch of First-of-its-Kind Microbubble-Powered, Large-Scale Cell Isolation Kit for Leukopaks
21 sept. 2022 09h00 HE | Akadeum Life Sciences
ANN ARBOR, Mich., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Akadeum Life Sciences, Inc., a global leader in buoyancy-based cell separation technology, announces a new early access program launch of an...
Akadeum logo.jpg
Akadeum Life Sciences Granted Transformative Patent for Buoyancy-Based Cell Separation “Microbubble” Technology
20 juin 2022 09h00 HE | Akadeum Life Sciences
ANN ARBOR, Mich., June 20, 2022 (GLOBE NEWSWIRE) -- Akadeum Life Sciences, Inc., a global leader in buoyancy-based technology in cell therapy manufacturing, clinical diagnostics, and cell and...